DDInter948 DDInter1163
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Metaxalone is a moderate to strong muscle relaxant used in the symptomatic treatment of musculoskeletal pain caused by strains, sprains, and other musculoskeletal conditions. It is marketed by King Pharmaceuticals under the brand name Skelaxin®. Its main mechanism of action is thought to involve general central nervous system depression. Metaxalone is associated with few side effects and is available as a 800 mg scored tablet.
Metaxalone {u} (Compound) upregulates {v} (Gene) TGFB3
Metaxalone {u} (Compound) is included by {v} (Pharmacologic Class) Centrally-mediated Muscle Relaxation
Metaxalone {u} (Compound) downregulates {v} (Gene) PCNA
Metaxalone {u} (Compound) causes {v} (Side Effect) Hypersensitivity
Metaxalone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cyclizine
Metaxalone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Methotrexate
Metaxalone {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Metaxalone {u} may lead to a major life threatening interaction when taken with {v} Morphine
Metaxalone (Compound) upregulates TGFB3 (Gene)
Metaxalone (Compound) is included by Centrally-mediated Muscle Relaxation (Pharmacologic Class)
Metaxalone (Compound) downregulates PCNA (Gene)
Metaxalone (Compound) causes Hypersensitivity (Side Effect)
Metaxalone may cause a moderate interaction that could exacerbate diseases when taken with Cyclizine
Metaxalone may cause a moderate interaction that could exacerbate diseases when taken with Methotrexate
Metaxalone may lead to a major life threatening interaction when taken with Teriflunomide
Metaxalone may lead to a major life threatening interaction when taken with Morphine